There were 1,096 press releases posted in the last 24 hours and 194,889 in the last 365 days.

Keryx Biopharmaceuticals to Webcast its Presentations at Investor Healthcare Conferences in November 2017

/EIN News/ -- BOSTON, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc, (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced it will webcast corporate presentations at the following investor conferences in November:

  • Stifel’s 2017 Healthcare Conference in New York City on Tuesday, November 14, 2017 at 3:30 p.m. ET
  • Jefferies’ 2017 Global Healthcare Conference in London, UK, on Thursday, November 16, 2017 at 8:40 a.m. GMT (3:40 a.m. ET)
  • A fireside chat at the 29th Annual Piper Jaffray Healthcare Conference in New York City on Tuesday, November 28, 2017 at 2:00 p.m. ET

Live audio webcasts of the presentations will be accessible from Keryx Biopharmaceuticals’ website at within the Investor Relations section under “webcasts and presentations.” An archived version of the webcast will be available for at least 15 days following the conclusion of the live presentations.

About Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc., with headquarters in Boston, Massachusetts, is focused on the development and commercialization of innovative medicines that provide unique and meaningful advantages to people with kidney disease. The Keryx team consists of more than 200 committed people working with passion to advance the care of people with this complex disease. This dedication has resulted in two FDA-approved indications for Keryx’s first medicine, Auryxia® (ferric citrate) tablets.

Lora Pike
Senior Director, Investor Relations & Corporate Communications
T: 617-466-3511